Stephen Stamp is the founder of Biodexa Pharmaceuticals. Biodexa Pharmaceuticals has raised $6M in total funding. Latest round: Seed.
Stephen Stamp is the Chief Executive Officer and CFO of Biodexa Pharmaceuticals PLC, a clinical-stage biopharmaceutical company listed on NASDAQ. He leads the company's development of innovative products focused on treating gastrointestinal cancers and other diseases with unmet medical needs.
Full founder directory · Investor directory · Company funding database · Fundraising library